Skip to main content
Clinical Trials/CTRI/2024/02/062846
CTRI/2024/02/062846
Recruiting
未知

A retrOspective, multi-centre study to evalUate the effecTiveness of different antibiotics/ Combinations being used in patients with bloOd stream infection and/ or hospital acquired pneuMonia caused by CRE (Klebsiella pneumoniae, Escherichia coli), CRAB & CRPA. - OUTCOME

Dr Deepak Govil0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: A415- Sepsis due to other Gram-negativeorganisms
Sponsor
Dr Deepak Govil
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Dr Deepak Govil

Eligibility Criteria

Inclusion Criteria

  • Adult more than 18 years of age with confirmed culture based diagnosis of hospital acquired pneumonia (HAP) (pneumonia developing at least 48 hours after hospital admission) and / or blood stream infection caused by CRE (Klebsiella pneumoniae, Escherichia coli) CRAB \& CRPA
  • Received antibiotic mono and or combination therapy for at\-least 48 hours as per clinician’s discretion

Exclusion Criteria

  • Culture positive from any site other than blood stream/ pneumonia.
  • Any organism other than CRE (Klebsiella pneumoniae, Escherichia coli), CRAB \& CRPA isolated within 14 days of initiation/ EOT of antibiotic therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials